[PDF] Top 20 Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants

... in presentation and severity from patient to patient, particularly in its neurodevelopmental effects? How early can we identify patients with TSC? Could targeted treatment safely and effectively modify the course ... See full document

... the presentation of a fixation stimulus that had a variable inter-trial interval of 800 and 1200 ms to reduce stimulus repetition effects and ensure the child could not predict the onset of the face ... See full document

... of infants showing par- oxysmal activity on EEG before the onset of clinical sei- zures (preventative treatment): that group achieved better seizure control and had better cognitive outcome at age 24 months ... See full document

... the presentation of a fixation stimulus that had a variable inter-trial interval of 800 and 1200 ms to reduce stimulus repetition effects and ensure the child could not predict the onset of the face ... See full document

... the diagnosis difficult. No typical disease presentation is known, and the clinical presentation usually differs between pediatric and adult ...The diagnosis of a patient with TSC is dependent ... See full document

... Of importance is the approach that study authors take to the diagnosis of ASD. We intend to report on the method used for diagnosis. We recognise that some studies will diagnose subjects with ASD using a ... See full document

... Clinically, patients may present with a mass lesion or increased intra-cranial pressure due to hydrocephalus, cranial nerve paralysis, myelopathy, convulsive seizures, and so forth [11]. Most cases of melanoma arising ... See full document

... A total of 84 charts were reviewed as part of this study (Figure 1). Of these, 49 were excluded due to no docu- mented mutational analysis (36) or age > 25 years at the time of diagnosis (13). Thus, a total of ... See full document

... nial tuberous sclerosis findings in early infancy is quite characteristic, the presence of a solitary or a few hyperintense lesions can pose a diagnostic ...noncalcified tuberous scle- rosis lesions ... See full document

... Genetic testing might also be considered in individuals who have a possible diagnosis of TSC based on the diag- nostic criteria listed in Table 1 (either one major feature or two or more minor features). Detection ... See full document

... for Infants. By the age of 12 months, infants with TSC who were later diagnosed with ASD demonstrated significantly greater cognitive delays compared to infants with TSC without ... See full document

... a diagnosis of TSC participated in this prospective ...The diagnosis of TSC was established in all patients by standardized examination using diagnostic criteria estab- lished at the Tuberous ... See full document

... In addition to brain, other organs are prominently involved in TSC. As befitting a neurocutaneous disease, skin involvement is very common and often leads clinicians to suspect the correct underlying diagnosis. ... See full document

... mTOR inhibitors may also be a rational candidate for the management of neurodevelopmental/neuropsychiatric dis- abilities associated with TSC, including intellectual disabil- ity and autism. Indeed, a recent preclinical ... See full document

... Address correspondence to Katarzyna Kotulska, MD, PhD, Department of Science, Department of Neurology and Epileptology, The Children ’ s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland. E-mail: ... See full document

... The age of onset of seizures and the time to response to treatment are the most important predictors of cognitive development in children with TSC. 18 – 20 Also, the age of seizure onset and severity of autistic features ... See full document

... A recent review of patient decision-making factors regarding PGD found that patients were highly motivated by the prospect of a healthy child free from the genetic condition; however, patients recognized the decision to ... See full document

... likely to have highly curved turns susceptible to this computation limitation. The range of age of our patients was wide (4 –30 years). Myelination is active in early childhood and may affect the quan- tity of generated ... See full document

... Ongoing clinical trials indicate that rapalogs show remarkable clinical potential in a variety of diseases. Although the anticancer effects of rapalogs may be augmented in combination with other agents, we must fully ... See full document

... Microcystic lymphatic malformations (MLM) are low-flow vascular malformations composed of multiple small cysts. MLM usually affect deep- lying structures, which makes their treatment even more difficult and ... See full document